Uniphar has launched Uniphar | Global Sourcing, a new identity for its On Demand business that strengthens its position as a strategic sourcing partner across international healthcare markets. The new name reflects the evolving role of the business as a strategic global partner to manufacturers and healthcare providers worldwide in sourcing and delivering essential medicines.
The rebrand is a key step in Uniphar’s broader strategy to integrate its global operations, boost internal collaboration, and offer a seamless, high-value experience for customers, partners, and suppliers.
As the first step in this transition, BModesto Group - headquartered in the Netherlands - will adopt the Uniphar brand at the group level and operate as Uniphar | Global Sourcing in the market. Brands including BModesto, BMclinical, BMmedical, Doncaster Pharma, SynCo Pharma, Uniphar Clinical, Durbin UK, Durbin PTSI US, Pharmasource, Ostomysource and Orspec Pharma will retain their local names while benefiting from the scale and synergies of the global platform.
“The rebrand to Uniphar | Global Sourcing marks a significant milestone in our commitment to building an integrated and agile global sourcing business,” said Dermot Ryan, COO, Uniphar. “BModesto Group’s transition is the first of several steps in strengthening our identity, simplifying market engagement, and enhancing our sourcing and supply value propositions worldwide.”
“This strategic repositioning unites teams across the business,” Ryan continued, “enabling faster response times, smarter solutions, stronger global partnerships, and ultimately, better access to medicines for patients worldwide.”